Diagnosis and medical treatment of fungal keratitis

A significant trend is a move away from yeast infections and toward filamentous fungal keratitis over the past decade

Diagnosis and medical treatment of fungal keratitis
Leigh Spielberg
Leigh Spielberg
Published: Thursday, February 16, 2017
[caption id="attachment_7579" align="alignnone" width="750"]Matthew Burton Matthew Burton[/caption] Matthew Burton PhD, London, UK, gave the keynote speech on infectious keratitis at the annual Cornea Day, during the 21st ESCRS Winter Meeting in Maastricht, The Netherlands. “A significant trend is a move away from yeast infections and toward filamentous fungal keratitis over the past decade, which currently cause 70% of fungal infections in our hospital,” said Dr Burton. A reverse trend has been noted in candida infections. Regarding the diagnostic approach, Dr Burton advised delegates to focus on potential risk factors, including contact lens use, ocular surface disease, trauma, surgery and especially tropical travel. “Travel history is often overlooked, despite it’s great importance,” said Dr Burton. The closer the patient has travelled to the equator, the higher the proportion of fungal keratitis. Diagnostics should include in vivo confocal microscopy (IVCM), scrape for microbiology, PCR and biopsy. "IVCM can be a very valuable modality, particularly for deeper infections not amenable to the other diagnostic approaches," he said.
IVCM can be a very valuable modality, particularly for deeper infections not amenable to the other diagnostic approaches
Dr Burton also reviewed the evidence that guided his approach to treatment. The most valuable studies compared topical treatments such as natamycin, voriconazole and chlorhexidine, as well as oral and intrastromal voriconazole. Dr Burton reminded delegates to be particularly careful with oral voriconazole, which can lead to fatal hepatotoxicity. “Despite the potential for success of medical treatments, don’t be afraid to consider surgery with there’s no treatment response or when the limbus becomes involved,” he concluded.
Latest Articles
ESCRS Today 2025: Happy Anniversaries!

ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.

Read more...

ESCRS Today 2025: A Congress for Everyone

From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.

Read more...

ESCRS Today 2025: All Eyes on Innovation

Watching out for obstacles and opportunities

Read more...

Beyond the Numbers

Empowering patient participation fosters continuous innovation in cataract surgery.

Read more...

Thinking Beyond the Surgery Room

Practice management workshop focuses on financial operations and AI business applications.

Read more...

Aid Cuts Threaten Global Eye Care Progress

USAID closure leads retreat in development assistance.

Read more...

Supplement: ESCRS Clinical Trends Series: Presbyopia

Read more...

Debate: FS-LASIK or KLEx for Hyperopia?

FS-LASIK has more of a track record, but KLEx offers advantages.

Read more...

Four AI Applications Ready for Practice

Commercial offerings may save time, improve practice and research.

Read more...

Perioperative Medication Regimens for Cataract Surgery

Randomised controlled clinical trial results provide evidence-based guidance.

Read more...